DE69026016D1 - Verwendung von 2-Cycloalkylamino-Oxazolinen zur Senkung oder Stabilisierung des intraokulären Druckes - Google Patents

Verwendung von 2-Cycloalkylamino-Oxazolinen zur Senkung oder Stabilisierung des intraokulären Druckes

Info

Publication number
DE69026016D1
DE69026016D1 DE69026016T DE69026016T DE69026016D1 DE 69026016 D1 DE69026016 D1 DE 69026016D1 DE 69026016 T DE69026016 T DE 69026016T DE 69026016 T DE69026016 T DE 69026016T DE 69026016 D1 DE69026016 D1 DE 69026016D1
Authority
DE
Germany
Prior art keywords
intraocular pressure
oxazolines
cycloalkylamino
stabilize
stabilize intraocular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69026016T
Other languages
English (en)
Other versions
DE69026016T2 (de
Inventor
Charles Gluchowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of DE69026016D1 publication Critical patent/DE69026016D1/de
Application granted granted Critical
Publication of DE69026016T2 publication Critical patent/DE69026016T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
DE69026016T 1989-09-26 1990-09-26 Verwendung von 2-Cycloalkylamino-Oxazolinen zur Senkung oder Stabilisierung des intraokulären Druckes Expired - Fee Related DE69026016T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/412,528 US5034406A (en) 1989-09-26 1989-09-26 Method for reducing or maintaining intraocular pressure

Publications (2)

Publication Number Publication Date
DE69026016D1 true DE69026016D1 (de) 1996-04-25
DE69026016T2 DE69026016T2 (de) 1996-09-05

Family

ID=23633363

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69026016T Expired - Fee Related DE69026016T2 (de) 1989-09-26 1990-09-26 Verwendung von 2-Cycloalkylamino-Oxazolinen zur Senkung oder Stabilisierung des intraokulären Druckes

Country Status (6)

Country Link
US (1) US5034406A (de)
EP (1) EP0420606B1 (de)
JP (1) JP2997308B2 (de)
AT (1) ATE135574T1 (de)
DE (1) DE69026016T2 (de)
ES (1) ES2084006T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US6323204B1 (en) 1993-10-13 2001-11-27 Allergan Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
EP1285657A3 (de) * 1993-10-13 2003-08-20 Allergan, Inc. Verfahren zur Verwendung von (2-imidazolin-2-yl-amino) Quinoxalinderivaten
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
JP5433576B2 (ja) * 2007-08-15 2014-03-05 アラーガン インコーポレイテッド アドレナリン作動化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670753A1 (de) * 1966-09-27 1970-07-16 Bayer Ag Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
US3676798A (en) * 1969-10-13 1972-07-11 Sperry Rand Corp Cooling system for lasing media
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
GB8610909D0 (en) * 1986-05-03 1986-06-11 Beecham Group Plc Compounds
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers

Also Published As

Publication number Publication date
JP2997308B2 (ja) 2000-01-11
EP0420606B1 (de) 1996-03-20
US5034406A (en) 1991-07-23
ATE135574T1 (de) 1996-04-15
DE69026016T2 (de) 1996-09-05
JPH03130224A (ja) 1991-06-04
EP0420606A3 (en) 1992-01-22
EP0420606A2 (de) 1991-04-03
ES2084006T3 (es) 1996-05-01

Similar Documents

Publication Publication Date Title
GR3015558T3 (en) Chemically modified protein and production thereof.
HUT43599A (en) Process for production of derivatives of thiazolidindion and medical compounds containing those
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
ES8707947A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
LV10083A (lv) Panemiens (6S)- un (6R)-tetrahidrofolijskabes iegusanai
DE3888340T2 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE69026016T2 (de) Verwendung von 2-Cycloalkylamino-Oxazolinen zur Senkung oder Stabilisierung des intraokulären Druckes
FI881104A0 (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
ATE100077T1 (de) 2-hydroxy-3-phenoxypropylaminoverbindungen.
DK0426416T3 (da) Hidtil ukendte morpholinolforbindelser, deres fremstilling af anvendelse
ES8801619A1 (es) Procedimiento para la obtencion de n-6-metoxi-5(perfluoroal-quil)-1-naftoil-n-metilglicinas y sus analogos tionaftoili- cos
FI95247C (fi) Menetelmä lääkeaineina käytettävien 1,3-tiatsolidinien -karbonyylikarboksiamidien valmistamiseksi
HUT49283A (en) Process for production of medical compositions applicable for treatment of peptical ulcer
DK0432841T3 (da) Spiro-indolin-oxazin-forbindelser med fotokromatiske og fotosensibiliserende egenskaber samt fremgangsmåde til deres fremstilling
DE3163803D1 (en) 2-methyl-5-thiazole-methylamine and carboxamide derivatives
CA2022221A1 (en) N-n'-disubstituted and n,n,n'-or n,n',n'-trisubstituted thioureas
JPS6445360A (en) 1-benzyl-4-hydroxy-2-pyrrolidone derivative and production thereof
ES8507526A1 (es) Un procedimiento para preparar una 2-(nitrometilen)-tetrahidro-2h-1,3-tiazina sustituida en n
ATE108444T1 (de) 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee